Popular drugs for diabetes and weight loss could have an unexpected side effect. Glucagon-like peptide 1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked ...
Type 2 diabetes is among the top causes of vision loss and blindness across the world. According to studies, visual impairment due to diabetic retinopathy has increased significantly in the last 20 ...
TUESDAY, Dec. 16, 2025 (HealthDay News) -- Texture analysis can identify retinal changes during early stages of type 2 diabetes, according to a study published in the December issue of Eye Vision.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback